Literature DB >> 7742750

Allogeneic bone marrow transplantation for fucosidosis.

A Vellodi1, H Cragg, B Winchester, E Young, J Young, C J Downie, R D Hoare, R Stocks, G K Banerjee.   

Abstract

Bone marrow transplantation was performed on an 8-month-old boy who was diagnosed as having fucosidosis following the diagnosis of the disease in his older brother. Although he was asymptomatic and his development was normal, abnomalities were found on an MRI scan prior to transplant. In the absence of a suitable related donor, an unrelated volunteer donor was used. Conditioning for the transplant consisted of busulphan and cyclophosphamide. Graft-versus-host disease prophylaxis consisted of in vitro T cell-depletion of the bone marrow and in vivo administration of cyclosporin. The post-transplant period was complicated by moderately severe graft-versus-host disease. Engraftment was documented by the presence of donor levels of alpha-fucosidase, donor blood group and tissue type (difference in the DQ antigen), and chromosomal polymorphism pattern of donor origin. Eighteen months after transplant, there is evidence of mild neurodevelopmental delay. By contrast, his elder sibling showed far greater developmental delay at the same age. The patient's MRI scan shows improvement. We believe this to be the first case of human fucosidosis treated by bone marrow transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7742750

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.

Authors:  Arun Babu Kumar; Xinying Hong; Fan Yi; Tim Wood; Michael H Gelb
Journal:  Mol Genet Metab       Date:  2019-06-10       Impact factor: 4.797

2.  Fucosidosis: genetic and biochemical analysis of eight cases.

Authors:  H Cragg; M Williamson; E Young; J O'Brien; J Alhadeff; S Fang-Kircher; E Paschke; B Winchester
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

3.  MR brain imaging of fucosidosis type I.

Authors:  P Galluzzi; A Rufa; P Balestri; A Cerase; A Federico
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

4.  Brain abnormalities in fucosidosis: transplantation or supportive therapy?

Authors:  Minyan Jiang; Sha Liu; Hua Jiang; Yunting Lin; Yongxian Shao; Hao Hu; Xiaoyuan Zhao; Hongsheng Liu; Yonglan Huang; Li Liu
Journal:  Metab Brain Dis       Date:  2017-02-25       Impact factor: 3.584

5.  Lysosomal Storage Diseases.

Authors:  Edward M. Kaye
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

6.  Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.

Authors:  Jessica L Fletcher; Gauthami S Kondagari; Charles H Vite; Peter Williamson; Rosanne M Taylor
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

7.  The molecular defect underlying canine fucosidosis.

Authors:  B J Skelly; D R Sargan; M E Herrtage; B G Winchester
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

Review 8.  Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Authors:  Reuven Or; Memet Aker; Michael Yechiel Shapira; Igor Resnick; Menachem Bitan; Simcha Samuel; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-30

9.  Ocular findings in a patient with fucosidosis.

Authors:  Lucía Rivera Sánchez; Julius T Oatts; Jacque L Duncan; Seymour Packman; Anthony T Moore
Journal:  Am J Ophthalmol Case Rep       Date:  2016-10-13

10.  The effects of intracisternal enzyme replacement versus sham treatment on central neuropathology in preclinical canine fucosidosis.

Authors:  Gauthami Sudhamayee Kondagari; Jessica Louise Fletcher; Rachel Cruz; Peter Williamson; John J Hopwood; Rosanne Maree Taylor
Journal:  Orphanet J Rare Dis       Date:  2015-11-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.